1. New guidelines concerning in utero drug exposure during pregnancy

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. FDA rules for biological products

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. The 50-year use of gentian violet may soon come to an end

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. The rate of serious reactions to antimalarial agents

   Newsletter Article 27 January 2013 Pages: 2 - 3

5. Alteplase

   Newsletter Article 27 January 2013 Pages: 3 - 3

6. Amphetamine abuse

   Newsletter Article 27 January 2013 Pages: 3 - 3

7. Anaesthetics/atropine/suxamethonium

   Newsletter Article 27 January 2013 Pages: 3 - 4

8. Antineoplastics

   Newsletter Article 27 January 2013 Pages: 4 - 4

9. Atropine see Anaesthetics/atropine/suxamethonium

   Newsletter Article 27 January 2013 Pages: 4 - 4

10. Carbamazepine see Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 4 - 4

11. Chlorpromazine see Lithium/chlorpromazine/flunitrazepam

    Newsletter Article 27 January 2013 Pages: 4 - 4

12. Clindamycin

    Newsletter Article 27 January 2013 Pages: 4 - 4

13. Cocaine abuse

    Newsletter Article 27 January 2013 Pages: 4 - 4

14. Cyclophosphamide

    Newsletter Article 27 January 2013 Pages: 4 - 4

15. Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 4 - 4

16. Digoxin interaction

    Newsletter Article 27 January 2013 Pages: 4 - 5

17. Digoxin overdose

    Newsletter Article 27 January 2013 Pages: 5 - 5

18. Ethyl chloride

    Newsletter Article 27 January 2013 Pages: 5 - 5

19. Flunitrazepam see Lithium/chlorpromazine/flunitrazepam

    Newsletter Article 27 January 2013 Pages: 5 - 5

20. Gentamicin see Digoxin interaction

    Newsletter Article 27 January 2013 Pages: 5 - 5

21. Gold

    Newsletter Article 27 January 2013 Pages: 5 - 5

22. Granulocyte-macrophage colonystimulating factor

    Newsletter Article 27 January 2013 Pages: 5 - 5

23. Guanfacine overdose

    Newsletter Article 27 January 2013 Pages: 5 - 5

24. Halothane

    Newsletter Article 27 January 2013 Pages: 5 - 5

25. Insulin

    Newsletter Article 27 January 2013 Pages: 6 - 6

26. Insulin human

    Newsletter Article 27 January 2013 Pages: 6 - 6

27. Interleukin 2

    Newsletter Article 27 January 2013 Pages: 6 - 6

28. Leuprorelin

    Newsletter Article 27 January 2013 Pages: 6 - 6

29. Lithium

    Newsletter Article 27 January 2013 Pages: 6 - 6

30. Lithium/chlorpromazine/flunitrazepam

    Newsletter Article 27 January 2013 Pages: 6 - 6

31. Lovastatin

    Newsletter Article 27 January 2013 Pages: 6 - 6

32. Methamphetamine abuse

    Newsletter Article 27 January 2013 Pages: 6 - 7

33. Methotrexate

    Newsletter Article 27 January 2013 Pages: 7 - 7

34. Metoclopramide

    Newsletter Article 27 January 2013 Pages: 7 - 7

35. Naproxen/salsalate

    Newsletter Article 27 January 2013 Pages: 7 - 7

36. Psoralens + ultraviolet A light

    Newsletter Article 27 January 2013 Pages: 7 - 8

37. Rifampicin

    Newsletter Article 27 January 2013 Pages: 8 - 8

38. Salsalate see Naproxen/salsalate

    Newsletter Article 27 January 2013 Pages: 8 - 8

39. Streptokinase

    Newsletter Article 27 January 2013 Pages: 8 - 8

40. Suxamethonium see Anaesthetics/atropine/suxamethonium

    Newsletter Article 27 January 2013 Pages: 8 - 8

41. Triamcinolone

    Newsletter Article 27 January 2013 Pages: 8 - 8

42. Zidovudine

    Newsletter Article 27 January 2013 Pages: 8 - 8